Skip to main content
Dose-Response logoLink to Dose-Response
. 2026 Apr 16;24(2):15593258261419666. doi: 10.1177/15593258261419666

Factors Associated With CT Scan Repetition in Pediatrics and Its Relationship With Cancer Risk: A Systematic Review and Meta-Analysis

Tahani Al-Shangeeti 1, Rozilawati Ahmad 1,, Salah A Alshehade 2, Maisa Elzaki 3, Fahad A Alothaim 4, Walaa Alsharif 3, Khaled Soliman 5, Amjad Al-Shangeeti 6, Bandar Al-Shamrani 7, Abdullah Hanbali 7, Tariq Almuzaini 8, Mohammed Alnasser 9, Taher Althubyani 10, Abdullah Aljohani 8, Ahmed Mahdi Baba 11, Amal Zaki Alruwaili 10, Hamid Osman Hamid Osman 12, Mohammed Abdullah Alshawsh 13,14,
PMCID: PMC13100438  PMID: 42028180

Abstract

Background

Rising use of pediatric CT scans has heightened concerns about radiation exposure compared to non-ionizing imaging modalities. This systematic review investigated factors contributing to repeat CT scans in children and assessed their association with cancer risk.

Main body

Main body: A comprehensive search of Web of Science, Scopus, and PubMed identified 30 eligible studies, with five studies involving over seven million participants included in the meta-analysis. CT exposure was associated with a significantly increased overall cancer risk (RR = 1.49, 95% CI: 1.44-1.54). Risk of brain tumors was significantly elevated (RR = 1.55, 95% CI: 1.22-1.97), whereas evidence for leukemia was less conclusive (RR = 1.23, 95% CI: 0.72-2.12). A dose-response relationship was observed, with patients receiving two or more CT scans showing substantially higher cancer risk (RR = 2.51, 95% CI: 1.74-3.61) compared with a non-significant risk for those receiving only one scan (RR = 1.07, 95% CI: 0.73-1.56).

Conclusion

These results highlight the need for practical pediatric CT guidelines. CT scans should be performed only when clinically justified, using optimized low-dose protocols and non-ionizing imaging alternatives when appropriate. Future research should develop evidence-based recommendations that balance diagnostic benefits with the long-term risks of radiation exposure, ensuring safe and effective imaging practice for children.

Keywords: computed tomography, CT scan, cancer risk, radiation exposure, pediatric radiation, cumulative doses, systematic review, meta-analysis


Graphical Abstract.

Graphical Abstract

Background

Computed tomography (CT) is an advanced medical imaging technique that uses X-rays and computer processing to obtain detailed cross-sectional images of the body. 1 CT scanning provides important diagnostic information to assist medical evaluation and treatment planning. However, there are concerns about radiation exposure risks from CT scans, especially in more radiosensitive pediatric patients. 2 Ionizing radiation from medical imaging can damage DNA and potentially cause cancer. Pediatric patients are especially vulnerable to radiation risks, given their developing bodies and longer life expectancy for potential radiation-induced cancer development. 3 Over the last two decades, there has been a significant increase in the use of pediatric CT scans. CT scans emit ionizing radiation levels that are substantially higher than those of conventional radiography by a factor of 100-500. 4 This heightened exposure to ionizing radiation has raised concerns regarding its potential correlation with increased cancer risk. 5 Several studies have found increased cancer risks associated with CT scan radiation, particularly in pediatric patients. A cohort study found that pediatric patients who underwent multiple CT scans had a small but real increase in leukemia and brain cancer risks. Another retrospective cohort study indicated increased lymphoma, leukemia, lung, and liver cancer risks in pediatric patients receiving CT scans compared with those who did not. 6 These risks highlight the need to limit unnecessary CT scans in pediatric patients. However, recent studies have indicated an increased utilization of CT scans in pediatric patients. 7 Repeating CT scans further amplifies the cumulative radiation exposure and potential cancer risk. 3

Despite concerns regarding pediatric CT radiation, the factors influencing the unnecessary repetition of CT scans in pediatric patients remain unclear. A few studies have examined the trends and predictors of repeat CT scans in adults. 8 ; however, limited evidence exists for pediatric patients. Understanding the factors linked to unnecessary repetitive CT scanning in pediatric patients is crucial for optimizing its use and preventing excessive radiation exposure. Prior studies have examined the cancer risks associated with pediatric CT scans, 9 but have not focused on the factors linked to repetitive scans. Understanding the predictors of repeat CT scans in pediatric patients is crucial for optimizing scan utilization and limiting unnecessary radiation exposure.

Current literature highlights significant gaps in understanding the factors contributing to CT scan repetition in pediatric settings, raising concerns due to the increasing use of CT in pediatric practice and its potential long-term health implications.

Therefore, this systematic review aimed to identify patient-related, provider-related, and health system-related factors linked to the repetition of CT scans in pediatric patients. In addition, the meta-analysis aimed to assess cancer risk in pediatric patients with repeated CT scans compared to those with single scans. Lastly, this study aimed to identify effective strategies for minimizing unnecessary repeat CT scans in pediatric cases.

Methods

Protocol and Registration

This systematic review followed the latest guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement. We registered the review protocol in the International Prospective Register of Systematic Reviews (PROSPERO) database, which can be accessed at https://www.crd.york.ac.uk/PROSPERO, (ID: CRD42022342579). This protocol was published in 2023. 10

Search Strategy

Relevant studies were retrieved using standard database search terms. A search was performed using three online databases (PubMed, Scopus, and Web of Science) to identify pertinent studies. Google Scholar was employed to explore grey literature to guarantee the inclusion of all relevant studies. This systematic review included studies published in English between 2012 and 2024 exclusively. Two reviewers independently searched the relevant articles. Boolean AND/OR operators were used to connect the following search terms: Cumulative AND doses OR radiation AND dose) AND (CT-scan OR “CT scan” OR “CT scanning” OR “Computed Tomography”) AND (Tumor * OR cancer* OR Malignant* OR Tumor*) AND (Pediatric* OR Paediatric* OR child* OR infant*).

Selection Process of Included Studies

The initial article screening process was conducted separately by two reviewers. They independently assessed the titles and abstracts of the studies and categorized them into three groups: relevant, irrelevant, and uncertain. This systematic review and meta-analysis included studies that focused on pediatric patients aged <18 years who were exposed to CT scan radiation. It included any type of observational study, such as cohort studies, case-control studies, or experiments, if the specified population and outcomes were examined. The inclusion criteria specifically covered studies that investigated the relative risk of cancer incidence associated with single or repeated CT scan exposure among pediatric patients; the prevalent cancer types linked to these exposures; and the rates, cumulative doses, and reasons for multiple CT scan exposures. Studies involving hybrid CT modalities, such as PET/CT and SPECT-CT, phantom studies, and systematic reviews or meta-analyses, were excluded from the analysis. Peers deemed irrelevant by both reviewers were excluded. Following this, four additional reviewers examined the full text of the remaining studies using the eligibility criteria, and only studies that met all criteria were included. In the event of disagreement, the two reviewers held discussions to reach a consensus before making their final decisions. If any confusion or disagreement persisted, a third opinion was sought from the other reviewers and a final decision was made upon reaching consensus.

Data Extraction and Risk of Bias Assessment

To improve the clarity and quality of the language, a standardized data extraction form in the form of a Google Spreadsheet was employed to enhance the consistency and accuracy of data recording. The following information was extracted and documented: Study ID, author name, publication type, journal name, Title, Year, Country, number, age, and gender of children in the exposure group; number, age, and gender of children in the non-exposure group (comparator); CT scan details, including the number of exposures, CT scan repetition rate, duration, cumulative dose, organs/tissues scanned, the reason for scanning, frequency of scanning, and duration between multiple CT scan radiations; cancer incidence rate, expressed as risk ratio, odds ratio (OR), or relative risk; cancer types; the relationship between cancer risk and multiple CT scans; study duration; and risk factors.

Potential bias was assessed using the Newcastle-Ottawa Scale (NOS) for observational studies, a tool designed to evaluate the quality of non-randomized studies within a systematic review context. 11 NOS offers a thorough evaluation of the strength of evidence about the possible association between exposure and outcome. It assessed two crucial aspects: (i) the selection of appropriate studies to address the exposure-outcome relationship in question and (ii) how well these studies estimated the exposure-outcome relationship without significant bias risks. Each study’s evaluation was based on the available data. The NOS assessment concentrates on various key domains, including the selection of study groups, comparability of these groups, and ascertainment of outcomes. Specific criteria were used for each domain to gauge the risk of bias. Two independent assessors conducted the NOS-based risk assessment, and any disparities or disagreements were addressed through discussion involving a third assessor if necessary. This meticulous process guarantees the reliability and validity of the NOS assessment. The study groups were thoroughly scrutinized to ensure that they accurately represented the target population and were matched suitably in terms of pertinent characteristics. The comparability of the groups was evaluated to verify the similarity of all aspects between the groups, except for the exposure being investigated, which helped minimize the potential confounding factors. Furthermore, the outcome ascertainment was reviewed to confirm unbiased and appropriate outcome measurements and assessments. Specific criteria for each domain considered factors such as sample size, study design, potential sources of bias, and statistical methodologies employed. This systematic review was assessed using the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist, which ensures the inclusion of high-quality studies and adherence to rigorous reporting standards. 12

Strategy for Data Synthesis

The approach to synthesizing data involved first gathering both quantitative and qualitative data from each study. The qualitative findings are described in the text and tables. However, for quantitative data related to the outcomes, a meta-analysis was performed by combining homogeneous data across studies. The effect size was calculated as the risk ratio, based on the method reported in the included studies. The choice between random- and fixed-effects models was determined by primary studies to account for variations when calculating the overall estimate.

To assess heterogeneity, we used the I2 measure, which can be evaluated visually using a forest plot. An I2 value between 0 and 30% indicated low heterogeneity, 30-65% suggested moderate heterogeneity, and >65% indicated substantial heterogeneity. 13 We evaluated publication and selection biases by constructing a funnel plot and conducted a sensitivity analysis to test the strength and reliability of our findings.

Results

General Characteristics of the Included Studies

A total of 902 records were initially identified from databases and other sources. After removing 12 duplicate records, 890 records were screened, leading to the exclusion of 829 records based on the predefined criteria. Subsequently, 61 successful reports were retrieved. Following retrieval, 61 full texts were assessed for eligibility, resulting in the exclusion of 31 reports, including nine surveys, 14 phantom studies, and eight reviews. Ultimately, 30 studies were included in the review, of which 5 were included in the meta-analysis (Figure 1).

Figure 1.

Figure 1.

The PRISMA flow chart summarizes the systematic review process adapted from Ref. 12

These studies span a decade, from 2012 to 2023, underscoring the contemporary significance of our research topic. Approximately half of these studies (n = 17) were published during the most recent period (2018-2023), highlighting the dynamic evolution of this research domain (Table 1). Upon examining the regional distribution of publications in this systematic review, we identified discernible disparities. Asia emerged as the most prolific contributor, accounting for 38% of publications. By contrast, Africa exhibited the lowest representation, contributing only 3% of the publications, underscoring a marked regional discrepancy in research output.

Table 1.

Characteristics of the Included Studies

No. Ref Country Study design Participants CT protocols Type of cancers
Number Age (year) Male/female
1. 14 China Retrospective study 922 children ≤15 626/296 Head, paranasal sinus, chest Thyroid
2. 7 USA (diverse racial/ethnic) Retrospective observational 4,857,736 = observation
744 = for dose calculation
<15 Girls = 50% Head, chest, abdomen/pelvis, and spine Solid cancer and leukemia
3. 15 Netherland Cohort retrospective 168,394 ≤18 Head, chest, abdomen/pelvis, and extremities Brain leukemia
4. 1 Taiwan Retrospective 2756 ≤16 1439/1094 N/A Leukaemia, intracranial malignancy, lymphoma
5. 16 Japan Retrospective 763 0-19 424/339 Brain/head and neck, thorax, and abdomen N/A
6. 17 Canada Prospective multicenter cohort study 4060 0-16 2618/1442 Brain Trauma
7. 18 UK Cohort 1073 0-19 Head, chest, abdomen, and pelvis, non-head scan
8. 6 Taiwan Cohort 24,418 <18 Head Brain tumors, leukemia
9. 18 Japan Retrospective 980 <15 544/436 Head
10. 5 Australia Cohort 10,939,680 0-19 357119/323092 Brain, facial bone, chest, extremities, abdomen, pelvis, spine, neck, other Solid cancer, leukemia
11. 19 Sudan Retrospective 182 1.12 month - 10 years Head, chest, abdomen
12. 20 Finland Cohort 4372 <15 2272/2100 Head CT Leukemia
13. 21 Brazil Cohort 1006 0 - 17.83 545/461 Head Brain tumor
14. 22 France Cohort 27,362 <5 15869/11492 Head, neck, chest, abdomen, pelvis, extremities Risk of cancers
15. 23 Oman Retrospective 142 4-87 52/90 Head, sinuses
16. 24 Finland Retrospective 48,989 0-15 2766/21329 Head, neck, chest, abdomen, pelvis, extremities N/A
17. 9 England Retrospective cohort 78,604 leukemia & 17,6587 brain tumors 0-15 Leukemia: 953,634/764,937
Unknown = 2413
Brain: 657,169/529,372
Unknown = 1666
Head, abdomen, pelvis, chest Leukemia, brain
18. 25 Britain Retrospective cohort 180,000 <22 Head CT scan Leukemia, brain tumors
19. 26 Japan Retrospective 138,532 0-10 86,305/52,226 Head Brain, CNS
20. 3 France Cohort 67,274 0-10 N/A 138,532 head CT examinations Centre nervous system tumor, lymphoma, leukemia
21. 27 Spain Cohort retrospective 9.7 million 0-20 52,283/42,324 Head, face, cervical spine, Brain
22. 28 Canada Retrospective 157 <18 115/42 Head, face, spine, body (chest, abdomen, pelvis), extremities N/A
23. 29 UK Cohort 1073 0-19 N/A 1. Head
2. Chest
3. Abdomen and pelvis
N/A
24. 30 Australia Cohort 12,194,798 0-85 5,618,995/6,575,803 Abdomen, pelvis, chest, extremity, facial, bones, head, neck, spine spiral angiography N/A
25. 31 USA Retrospective analysis 487 5-13 301/186 Head CT, cervical spine, abdomen, chest N/A
26. 32 Iran Retrospective 932 18-57 544/388 Abdomen pelvis, routine chest, chest HR CT, brain, sinise examination N/A
27. 33 Turkey Cohort study 561 <18 373/188 Head CT Leukemia, CNS
28. 34 Switzerland Cohort study 522 0-15 291/231 Chest CT scan protocol Leukemia, colon liver, lung, ovary, stomach, breast, uterus
29. 35 Iran Cross-sectional study 90 <20 N/A Brain CT Thyroid
30. 36 Iran Retrospectives 19,800 0-15 2341/1610 Brain Leukemia, brain tumor

Furthermore, the overall risk of bias assessment showed that most of the studies had a low risk of bias (Figure 2). This was indicated by 16 studies that received scores of 7 or more. 12 studies scored between 5 and 6, indicating a moderate risk of bias, whereas two studies scored below 5, indicating a higher risk of bias (Supplemental Figure S1). Notably, all studies included in the meta-analysis had an overall low risk of bias.

Figure 2.

Figure 2.

The overall risk of bias assessment

Risk of Cancer Associated with CT Scan in Pediatric Patients

In this study, the association between CT scan exposure and cancer risk was examined by meta-analysis (Figure 3), which revealed that five studies were included,1,5,6,15,20 with a total of 7,244,376 participants in the CT-exposed group and 1,778,268,875 participants in the non-exposed group. There were 3360 cancer events in the CT-exposed group and 61,003 in the non-CT-exposed group. Using a random effects model, the meta-analysis found a pooled risk ratio (RR) of 1.49 (95% CI: 1.44 to 1.54, P < 0.00001), indicating a statistically significant increased risk of cancer among those exposed to CT scans compared to those not exposed. The study by Mathews et al contributed the largest weight to the analysis (95.1%) 5 ; however, removing this study data from the meta-analysis does not affect the significant level and the RR was 1.39 (95% CI: 91.19 – 163, P < 0.00001). The risk ratios from the individual studies ranged from 1.29 to 1.89, suggesting an increased risk of cancer with CT scan exposure. Although not all were statistically significant, they consistently showed elevated cancer risk following CT scan exposure. The heterogeneity between the studies was low (I2 = 0%), indicating consistency of the results.

Figure 3.

Figure 3.

A meta-analysis examined the association between exposure to CT scans and cancer in pediatric patients

Risk of Cancer Associated with CT-Scan Repetition and Cumulative Dose

Figure 4 shows the subgroup analysis of cancer risk according to the number of repeat CT scans. In the single repeat CT scan group, three studies with over 1.5 million participants found a non-significant pooled risk ratio of 1.07 (95% CI: 0.73 to 1.56, P = 0.75). Conversely, among children receiving two or more repeat CT scans, three studies with 7524 participants found a significantly increased risk ratio (RR = 2.51, 95% CI: 1.74 to 3.61, P < 0.0001), indicating that two or more CT scans were associated with a higher risk of cancer than one CT scan. Moderate heterogeneity was observed among studies with a single repeat CT scan (I2 = 33%), whereas low heterogeneity was observed among studies with two or more repeat CT scans (I2 = 0%). This finding provides evidence that cancer risk increases with the number of repeated CT scans in children.5,6,20

Figure 4.

Figure 4.

Subgroup analysis revealed that the cancer risk varied according to the number of repeat CT scans

Risk for Specific Types of Cancer

Figure 5 shows the subgroup analysis examining whether the cancer risk from CT scans differed by cancer type, including leukemia and brain tumors. For leukemia, two studies with 106,579 participants found a non-significant pooled risk ratio of 1.23 (95% CI: 0.72 to 2.12, P = 0.45), with moderate heterogeneity (I2 = 43%). In contrast, for brain tumors, three studies with 757,342 participants found a significantly increased pooled risk ratio of 1.55 (95% CI: 1.22 to 1.97, P < 0.00001), with low heterogeneity (I2 = 0%).

Figure 5.

Figure 5.

Subgroup analysis of cancer risk from CT scans varied according to cancer type

Leukemia

One study found that undergoing two to three repeat CT scans substantially increased the risk of blood cancer in children under five years of age, particularly with head CT scans. Furthermore, the risk of solid cancers is higher among younger patients and girls than among older children and boys. 7 Regarding the risk of leukemia, the estimated lifetime attributable risk (LAR) was highest for head scans in children under 10 years of age and decreased as the pediatric population grew older. Specifically, for pediatrics under 5 years of age, the projected risk was 1.9 cases per 10,000 scans. However, for children aged 10 to 14 years, this risk dropped to 0.5 cases per 10,000 scans. In the case of abdomen/pelvis scans, the leukemia risk ranged from 0.8 to 1.0 cases per 10,000 scans, while for chest and spine scans, it was estimated to be between 0.4 to 0.7 cases per 10,000 scans. Interestingly, among pediatrics aged 10 to 14 years, abdomen/pelvis scans exhibited the highest associated risk of leukemia, at 1.0 cases per 10,000 scans. To contextualize this, it was estimated that one case of leukemia could potentially result from 5250 head scans performed in children under 5 years of age and from every 21,160 scans in pediatric patients aged 10-14 years. 7 The anticipated number of future cancer cases, particularly in the context of leukemia and brain cancer, is a critical area of research and public health concern. Based on data from 19,800 brain CT scans conducted in Yazd Province, the projected number of future cases of brain cancer and leukemia were 4 and 1.7, respectively. These future estimates for the prevalence of leukemia and brain cancer were 1.8 and 0.75 for men, and 1.3 and 0.6 for women, respectively. Approximately one cancer case was attributed to childhood exposure that later developed into cancer, comprising 0.23 leukemia cases and 0.53 brain cancer cases. Examining the projected cancer rates within three distinct age groups, the total number of cases of brain cancer and leukemia was approximately 4.6 and 0.7, respectively. 37 Furthermore, a corroborating study identified a positive correlation between leukemia brain tumors, and radiation exposure resulting from CT scans. The ERR per mGy was 0.036 (95% CI: 0.005-0.120) for leukemia and 0.023 (95% CI: 0.010-0.049) for brain tumors. This study revealed that the leukemia risk may nearly triple with cumulative doses of approximately 50 mGy delivered during CT scans in pediatric patients, whereas the risk of brain cancer may almost triple with cumulative doses of approximately 60 mGy. 9 Conversely, another study found no association between the radiation dose to the bone marrow and the risk of all types of leukemia combined, with 44 cases analyzed. The ERR per 100 mGy was 0.21 (95% CI: −0.12 to 2.40) with a P-value of 0.68. This trend remained consistent for all leukemia and myelodysplastic syndromes (MDS) combined, with an ERR per 100 mGy of 0.04 (95% CI: −0.12 to 1.61) and a P-value of 0.92. 15 In the case of the most prevalent subtype, precursor B-cell acute lymphoblastic leukemia, there was an evident heightened risk linked to radiation exposure, with an OR of 0.14 mGy. Moreover, the excess OR for individuals who underwent any CT scan vs those who did not was 2.25 for acute lymphoblastic leukemia and 2.88 for precursor B-cell, respectively. These findings underscore the notably higher risk associated with specific leukemia types among individuals exposed to CT scans. 5

Solid Cancer

The estimated LAR of solid cancers decreases with increasing age, particularly for head and spinal scans. In contrast, the relationship between the abdomen/pelvis and chest scans was less consistent. Notably, the risk of solid cancers was found to be greater for females than for males, with the highest projected cases per 10,000 CT scans occurring for abdomen/pelvis scans (ranging from 25.8 to 33.9 cases for girls compared to 13.1 to 14.8 cases per 10,000 CT scans for males). 7 When specifically assessing the cancer risks associated with various organs following medical imaging, an increase was observed in comparison with naturally occurring lifetime estimates. In female neonates, this increase was 1.8%, 0.45 %, 0.45 %, and 0.39 % in the thyroid, stomach, lungs, and breasts, respectively. When these organ-specific risk increments for the analyzed cancer sites were summed, a cumulative increase of up to 3.6% in female neonates and 2.1% in male neonates was observed compared with natural risks. However, for females aged 10 years, these organ-specific increases were less pronounced, with increments of 0.57% in the thyroid, 0.19% in the stomach, 0.24 % in the lungs, and 0.18% in the breasts, resulting in a 1.3% (0.7% in 10-year-olds) cumulative increase in cancer risk. 34

Brain Tumors

A Taiwanese research study revealed that the hazard ratio (HR) for all types of brain tumors was significantly elevated, with a value of 2.56 (95% CI: 1.44-4.54, P < 0.01), in the cohort exposed to specific factors compared to the cohort without exposure. However, it is important to note that the overall risk of both malignant and benign brain tumors did not differ significantly between the two cohorts. Notably, the frequency of CT scans displayed a robust correlation with the incidence of all brain tumors, with the HR increasing from 2.32 to 10.4 (P < 0.001) compared to the unexposed cohort. 1 Another study found that the risk of developing benign brain tumors in Taiwan was 2.97 times higher among patients who underwent head CT scanning procedures during childhood than among those who did not undergo CT scans during childhood. Additionally, participants aged 7-12 years are more susceptible to benign brain tumors, and overall, those aged 0-6 years have the highest risk. 6 For all brain tumors, as well as malignant and non-malignant brain tumors considered separately, the relative risks notably increased, reaching two to four times the baseline risk in the highest dose category (120 mGy). The ERR per 100 mGy was 0.86 (95% CI: 0.20 to 2.22) for all brain tumors, 1.02 (95% CI: 0.01 to 4.30) for malignant brain tumors, and 0.78 (95% CI: 0.07 to 2.58) for non-malignant brain tumors. Importantly, there was no evidence of nonlinearity in these trends, as indicated by P-values of 0.72, 0.45, and 0.92 for the respective analyses. 15 Cerebral tumors are the most common radiation-related cancers, accounting for 25% of future cancer cases. 29 CT scan exposure increases the risk of various cancers, with higher risks being associated with specific solid, lymphoid, and hematopoietic cancers. The cumulative absolute excess incidence rate for all cancers was 9.38 per 100,000 person-years. 5

Thyroid

The LAR of thyroid cancer incidence in a 5-year-old child who underwent a single-head CT scan was found to be 8.8 per 100,000 in girls and 1.3 per 100,000 in boys. In the case of chest CT scans, the LAR was notably higher at 22.4 per 100,000 for girls and 3.2 per 100,000 for boys. However, for patients aged 5-10 years who underwent chest CT, LAR ranged from 16.0 per 100,000 to 44.7 per 100,000. This wide range can be attributed to variations in the age of the exposed patients and the frequency of repeated CT scans. 14 Additionally, a study reported that pediatric patients under the age of five years had an increased risk of thyroid cancer. According to the results of calculating the lifetime risk of thyroid cancer, the spiral technique has a much higher risk than the other techniques. 35 Organ-specific cancer risks were found to increase by up to 1.8 % in the thyroid, 0.45 % in the stomach, 0.45 % in the lungs, and 0.39% in the breasts of female neonates.

Factors Associated With CT-Scan Repetition in Pediatric Patients

Although it is essential to understand the key factors leading to the repetition of CT scans, there is a notable lack of comprehensive studies in the existing literature that address these factors. The factors identified in the available literature regarding the repetition of CT scans can be categorized into three main groups: clinical and technical (involving factors such as radiographer practices and scanning protocols) and patient-related factors such as motion during scanning (Table 2). A noteworthy cause of repeated CT examinations in pediatric patients is the diversity of imaging protocols, even within the same medical department. The inconsistent use of protocols by technologists can compromise image quality and diagnostic accuracy, necessitating additional scans. Furthermore, the application of adult protocols to pediatric patients, which do not account for their unique anatomical and physiological characteristics, often results in suboptimal imaging outcomes and requires repeated examinations. Therefore, it is imperative to establish standardized protocols tailored to pediatric patients to ensure optimal diagnostic results, while minimizing radiation exposure. Clinical factors also play a pivotal role in the repetition of CT examinations in the pediatric population. In resuscitation scenarios, multiple scans are often necessary to assess the effectiveness of resuscitative efforts and monitor changes in the patient’s condition over time. Repeat examinations are essential for re-evaluating injuries, particularly when initial imaging provides limited or inconclusive results. Additionally, changes in clinical status, such as worsening of symptoms or the emergence of new complications, may prompt the need for repeat CT examinations to facilitate accurate diagnosis and guide treatment planning. This systematic review also highlighted previous research indicating that patients with low Glasgow Coma Scale (GCS) scores may experience ongoing injury progression. Consequently, repeated imaging is recommended in such cases to monitor the evolving pathology and to adjust the treatment approach accordingly.

Table 2.

Factors Contributing to Radiation Exposure Variability in Pediatric CT Scanning

Factors Note
Inconsistent technologist practices Some technologists apply identical CT parameters for both adults and pediatric, leading to elevated radiation doses in pediatric patients
Deficient technologist training A significant issue arises from the inadequate training of technologists in pediatric dose optimization
Shielding absence Radiosensitive organ shielding, such as thyroid, gonad, or eye lens shields, are not employed by hospitals during pediatric CT scans, leaving these organs susceptible to scatter radiation
Wide variability in previous studies Past research has uncovered substantial variations in screening times, radiographic images, dose-length products, and effective doses in pediatric CT scans, indicating unnecessary radiation exposure
Variations across body regions Minor dose variations were observed for brain and chest CT scans, but significant discrepancies were found for abdominal CT scans, likely stemming from differences in clinical indications
Insufficient knowledge among healthcare professionals Variability in practice is exacerbated when technologists, radiologists, and referring physicians lack adequate knowledge about CT machine capabilities and radiation risks
Consistency in dose across CT modalities The study found consistent dose values across different CT modalities in all three hospitals
Lack of optimization implementation Examined hospitals did not implement CT dose optimization strategies, resulting in unnecessarily high radiation doses
Impact of CT scanner types The choice of CT scanner type affects radiation dose, with dual-slice or four-slice CT scanners delivering lower doses but potentially compromising image quality, while higher-slice CT modalities provide doses that exceed what is necessary
Variability due to data and protocols Variations in data provided in request forms and department protocols contribute to dose discrepancies
Significance of pediatric protocols The use of adult techniques and protocols in some cases highlights the importance of dedicated pediatric protocols for CT examinations in pediatrics
Need for referral criteria and staff training The study underscores the importance of establishing clear referral criteria and providing ongoing staff training in radiation protection concepts

Furthermore, it was reported that many patients undergo repeat CT scans primarily for injury reassessment rather than due to a change in their clinical condition. 28 Head injuries stand out as a prominent reason for the repetition of CT scans in pediatric cases, ensuring the accuracy of the diagnosis 33 revealed a significant disparity in radiation exposure levels. Pediatric head CT scans administered without following the specific pediatric protocol were associated with an average effective radiation dose that was twice as high as when the protocol was applied, measuring at 3.8 mSv as opposed to 1.6 mSv (P < 0.001). This underscores the importance of adhering to the appropriate scanning protocols to minimize radiation exposure in pediatric patients. 31

Notably, some technologists applied identical parameters to both adult and pediatric patients, further underscoring the need for specialized training among technologists to mitigate radiation exposure risks. Notably, studies conducted by ref. 7 Indicated that the hospitals under examination did not employ shielding measures such as thyroid, gonad, or eye lens shields to safeguard radiosensitive organs from scattered radiation. This highlights an area where improvements in radiation safety practices are required to enhance patient protection. Previous research has revealed significant disparities in screening duration, number of radiographic images taken, dose-length product, and effective dose in pediatric CT scans. These discrepancies highlight the trend of excessive and unwarranted radiation exposure in pediatric patients, indicating a lack of optimization in current clinical practices. Notably, the study also identified relatively minor variations in radiation doses for brain and chest scans but significant discrepancies in abdominal scans. These variations may be attributed to diverse clinical indications. Nevertheless, a crucial challenge is the insufficient knowledge of technologists, radiologists, and physicians regarding the capabilities of CT machines and their associated radiation risks. Despite the undeniable benefits of CT scans in pediatric medicine, there is an urgent and compelling need for enhanced training and optimization measures to minimize avoidable radiation exposure in pediatric patients. 7 It has been emphasized that patient motion could contribute to the need for rescanning. This observation was subsequently reinforced by ref. 38, who determined that CT scans were repeated primarily in cases involving older patients, females, and individuals with higher body mass indices due to patient movement. These studies collectively underscore the various reasons behind the repetition of CT scans, highlighting unnecessary radiation exposure, which can compromise patient satisfaction and health as well as waste valuable time and resources. Therefore, it is imperative to recognize the distinctive nature of CT scanning and consider these factors when developing strategies to minimize the repetition of scans, ultimately prioritizing patient well-being and radiation safety.

Discussion

This systematic review was undertaken to synthesize the existing evidence on strategies to minimize radiation exposure risks from CT scans in pediatric patients. A comprehensive literature search identified 30 studies that met the eligibility criteria, providing insights into the cancer risks of CT radiation and approaches to reduce unnecessary exposure in pediatric patients. However, the included studies demonstrated heterogeneity in study populations, interventions, and measured outcomes. Additionally, there is a lack of randomized controlled trials that specifically examine radiation-reduction strategies.

Growing concern regarding the potential cancer risks associated with repeated CT scan exposure in pediatric patients has increased substantial research interest. Accumulating evidence strongly suggests that an increased frequency of CT scans in pediatric patients leads to a higher cumulative radiation exposure, which is closely linked to an elevated average cancer risk. 7 Consequently, owing to the heightened incidence of cancer associated with this exposure, CT scans have been associated with a significant increase in the number of cancer cases.

Our meta-analysis demonstrated a pooled RR of 1.49 (95% CI: 1.44-1.54) for overall cancer risk associated with CT exposure, consistent with previous evidence. For example, Huang et al, 39 reported a comparable 1.32-fold increased cancer risk among more than 1.1 million CT-exposed children, reinforcing confidence in the association. For specific cancer types, we observed a significantly elevated risk of brain tumors (RR = 1.55, 95% CI: 1.22-1.97) but a non-significant association with leukemia (RR = 1.23, 95% CI: 0.72-2.12). This pattern aligns with Pearce et al.’s landmark UK cohort study, which reported excess relative risks of 0.023 per mGy for brain tumors and 0.036 per mGy for leukemia. 9 However, more recent evidence from the 2023 EPI-CT European cohort found an excess relative risk of 1.96 per 100 mGy for hematological malignancies, indicating that leukemia risk may be greater than earlier estimates with extended follow-up. 40 Differences between our leukemia findings and previous studies may reflect variations in sample size, duration of follow-up, and radiation dose assessment methods.

The dose-response relationship we observed, with multiple CT scans (RR = 2.51 for ≥2 scans) significantly increasing cancer risk compared with a single scan (RR = 1.07), is consistent with findings from previous studies. Huang et al, 6 and Mathews et al, 5 similarly reported cumulative dose effects, noting that brain tumor risk can increase two-to four-fold at cumulative doses above 120 mGy. 15 This collective evidence strongly reinforces the ALARA principle and highlights the importance of avoiding unnecessary repeat scans, particularly in younger children who have the greatest lifetime risk. Clinically, these findings underscore the need to apply the ALARA (as low as reasonably achievable) principle when using CT imaging in pediatrics. Dose-optimization strategies should be rigorously implemented, 5 including the use of child-specific protocols, adjustment of scanner settings based on patient size, minimizing scan range, and shielding radiosensitive tissues. 15

Among the most impactful technological advances in pediatric CT dose reduction is iterative reconstruction (IR), which has transformed how radiation exposure is managed. Compared with traditional filtered back projection (FBP), IR algorithms can reduce radiation dose by 30-50% while preserving diagnostic image quality. 41 More advanced approaches, such as model-based iterative reconstruction (MBIR) and deep learning image reconstruction (DLR) have demonstrated even greater dose savings, achieving reductions of 50-80% relative to standard protocols.42,43 A 2023 systematic review further showed that DLR outperforms conventional IR in pediatric head and cardiac CT, offering superior image quality at substantially lower doses. 44 Despite these benefits, clinicians should be aware that IR techniques can introduce a “smoothed” appearance and may reduce low-contrast spatial resolution, highlighting the need for careful protocol optimization. 42 Additional dose-reduction innovations, including automatic exposure control systems, low-tube-voltage techniques (eg, 80 kVp), and emerging photon-counting detector CT also show considerable promise for enhancing safety in pediatric imaging. 45 Overall, the implementation of these dose-optimization strategies, particularly IR and DLR methods, should be prioritized across pediatric CT services to minimize radiation exposure and reduce long-term cancer risk from medically necessary scans.

Our review identified protocol variability, insufficient staff training, and motion artifacts as major contributors to unnecessary repeat CT scans. These findings are consistent with previous literature but must be interpreted within the context of current evidence-based strategies aimed at reducing scan repetition. To address motion artifacts, one of the most common causes of rescanning, multiple non-sedation strategies have been developed. A recent 2025 quality improvement study demonstrated that adopting volumetric target-mode ECG-gated CT protocols significantly reduced scan times in children aged 0-4 years, thereby decreasing motion artifacts without increasing the need for sedation. 46 Advances in modern multislice CT systems, including sub-second gantry rotation times, now allow many pediatric examinations to be completed within a single breath-hold or with only minimal sedation, reducing reliance on deeper anesthesia. 47 Non-pharmacological techniques, such as “feed and swaddle” approaches for infants, behavioral rehearsal programs for toddlers, and child life specialist support, have also been shown to reduce motion-related scan repetition. 48 When sedation is not desirable, pediatric-specific immobilization devices, such as vacuum bean bags and Velcro-based restraints—offer additional means of minimizing patient movement. 49

Protocol standardization remains an unmet need. Evidence shows that implementing pediatric-specific CT protocols can reduce radiation doses by up to 50% while preserving diagnostic quality. 7 Despite this, our review indicates that many institutions, especially non-specialized centers continue to use adult protocols for pediatric patients. Integration of decision support systems into CT ordering workflows has reduced inappropriate imaging by 20-30% in several settings 50 suggesting that electronic clinical decision support may help prevent not only unnecessary initial scans but also avoidable repeat examinations. Future research should prioritize development of automated image-quality prediction tools capable of assessing scan adequacy in real time, which could reduce rescanning. Additionally, establishing international consensus guidelines for pediatric CT protocol standardization is essential to ensure consistent, safe, and high-quality imaging across diverse clinical environments.

Dose-optimization interventions specifically aimed at minimizing repetitive CT scans in pediatric patients require further study. Based on this evidence, potential strategies include checklists to justify CT use, the use of MRI as an alternative when feasible, defined criteria for scan repetition, mandatory second-reader confirmation before repeats, and peer review of protocols generating excessive repeats. Studying such targeted interventions can strengthen the evidence for minimizing repetitive CT scans and radiation exposure in pediatric patients.

This systematic review and meta-analysis had several limitations. First, there was a high heterogeneity in the selection of variables used to assess cancer risk across the included studies. This variability makes it challenging to establish consistent and comparable measures of cancer risk, compromising the reliability and generalizability of the findings. Therefore, caution should be exercised when concluding this study. Moreover, a notable limitation arises from the use of simulation or mathematical phantoms in some of the included studies to estimate organ doses rather than directly measuring them in pediatric patients. Although these methods are commonly used for radiation dose estimation, they introduce inherent uncertainty. Simulated organ doses may not fully capture individual variations in patient body size, anatomy, or other factors that can influence the actual organ doses. This reliance on simulated organ doses presents a substantial obstacle in accurately assessing the relationship between CT scan repetition and cancer risk in pediatric patients within the context of this review. In addition to these limitations, another significant constraint was the lack of clear explanations for why CT scans were repeated in some of the included studies. Understanding the underlying reasons for, and justifications for, repeated scans is pivotal for evaluating the potential impact of cumulative radiation exposure on cancer risk. Unfortunately, most studies have not offered explicit insights into the motivations for repeated CT scans. This lack of clarity hampers our ability to draw definitive conclusions regarding the association between CT scan repetition, cumulative dose, and its potential implications for cancer risk in pediatric patients. To address these limitations and advance our understanding of this critical area, future research should prioritize comprehensive reporting and in-depth investigations. A thorough exploration of the motivations and clinical justifications behind repeated CT scans in pediatric patients is essential to accurately determine the complex relationship between CT scan repetition and cancer risk.

Conclusion

This systematic review and meta-analysis provide compelling evidence that pediatric CT radiation exposure is associated with a significantly increased risk of cancer. Children exposed to CT scans had a 1.49-fold higher overall cancer risk compared with unexposed children (95% CI: 1.44-1.54). A clear dose-response pattern emerged, with children undergoing two or more CT scans experiencing more than double the cancer risk (RR = 2.51) relative to those with a single scan. Elevated risk was particularly evident for brain tumors (RR = 1.55), whereas evidence for leukemia was less consistent, indicating the need for careful evaluation of head CT use.

These findings highlight the need for stricter justification before ordering CT scans in children, especially repeat imaging, along with implementing standardized pediatric protocols that incorporate dose-reduction technologies. Greater use of non-ionizing alternatives when clinically appropriate and improved training for radiology staff are also essential. Future research should prioritize developing robust, evidence-based guidance on the appropriateness of repeat CT imaging and optimizing age-specific radiation dose strategies to ensure diagnostic value while minimizing long-term cancer risk.

Supplemental Material

Supplemental Material - Factors Associated With CT Scan Repetition in Pediatrics and Its Relationship With Cancer Risk: A Systematic Review and Meta-Analysis

Supplemental Material for Factors Associated With CT Scan Repetition in Pediatrics and Its Relationship With Cancer Risk: A Systematic Review and Meta-Analysis by Tahani Al-Shangeeti, Rozilawati Ahmad, Salah A. Alshehade, Maisa Elzaki, Fahad A. Alatheem, Wala Al-Sharif, Khalid Suliman, Amjad Al-Shangeeti, Bandar Al-Shamrani, Abdullah Hanbali, Tariq Almuzaini, Mohammed Alnasser, Taher Althubyani, Abdullah Aljohani, Ahmed Mahdi Baba, Amal Zaki Alruwaili, Hamid Osman Hamid Osman and Mohammed Abdullah Alshawsh in Dose-Response.

Acknowledgments

The authors would like to thank the librarians at the Faculty of Health Sciences, Universiti Kebangsaan Malaysia, and the Faculty of Medicine, Universiti Malaya for their assistance in accessing the databases and retrieving full-text articles.

Appendix.

List of Abbreviations

ALARA

As low as reasonably achievable

CI

Confidence interval

CNS

Central nervous system

CT

Computed tomography

ERR

Excess relative risk

GCS

Glasgow coma scale

HR

Hazard ratio

LAR

Lifetime attributable risk

MDS

Myelodysplastic syndromes

mGy

Milligray

mSv

Millisievert

NOS

Newcastle-Ottawa scale

OR

Odds ratio

PET

Positron emission tomography

PRISMA

Preferred reporting items for systematic reviews and meta-analyses

PROSPERO

International prospective register of systematic reviews

RR

Risk ratio

SFDA

Saudi food and drug authority

SPECT

Single-photon emission computed tomography

UK

United Kingdom

USA

United States of America

Author Contributions: TAS, MAA and RA conceptualized and designed the study; TAS, WAS, TA, TAM, AH, AAS, and MA conducted the systematic literature search and data extraction; TA, SAA, and MAA performed the statistical analysis and meta-analysis; KS, AAS, AZA, ME, and BAS assessed the risk of bias; TAS, SAA and MAA drafted the manuscript; TAS, RA, and MAA critically revised the manuscript for important intellectual content. All authors read and approved the final manuscript.

Funding: This work was financially supported by Universiti Kebangsaan Malaysia under Grant TAP-12779.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Supplemental Material: Supplemental material for this article is available online.

ORCID iDs

Tahani Al-Shangeeti https://orcid.org/0009-0006-6083-5992

Maisa Elzaki https://orcid.org/0000-0002-0627-194X

Fahad A. Alothaim https://orcid.org/0009-0003-5805-4650

Khaled Soliman https://orcid.org/0000-0003-1008-6103

Mohammed Abdullah Alshawsh https://orcid.org/0000-0001-8342-5183

Ethical Considerations

Not applicable. This systematic review and meta-analysis used previously published studies and did not involve direct human subjects or personal data collection.

Consent for Publication

Not applicable as no person’s data was included in any form.

Data Availability Statement

All data analyzed in this systematic review and meta-analysis are from published studies cited in the references. The datasets used for the meta-analysis are available from the corresponding author upon reasonable request.*

References

  • 1.Li IG, Yang YH, Li YT, Tsai YH. Paediatric computed tomography and subsequent risk of leukaemia, intracranial malignancy and lymphoma: a nationwide population-based cohort study. Sci Rep. 2020;10:7759. doi: 10.1038/s41598-020-64805-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Foucault A, Ancelet S, Dreuil S, et al. Childhood cancer risks estimates following CT scans: an update of the French CT cohort study. Eur Radiol. 2022;32:5491-5498. doi: 10.1007/s00330-022-08602-zi [DOI] [PubMed] [Google Scholar]
  • 3.Journy N, Rehel J-L, Ducou Le Pointe H, et al. Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France. Br J Cancer. 2015;112:185-193. doi: 10.1038/bjc.2014.526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Smith-Bindman R, Miglioretti DL. CTDI vol, DLP, and effective dose are excellent measures for use in CT quality improvement. Radiology. 2011;261:999. doi: 10.1148/radiol.11111055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ (Online). 2013;346:f2360. doi: 10.1136/bmj.f2360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Huang W-Y, Muo C-H, Lin C-Y, et al. Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort study. Br J Cancer. 2014;110:2354-2360. doi: 10.1038/bjc.2014.103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Miglioretti DL, Johnson E, Williams A, et al. The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr. 2013;167:700-707. doi: 10.1001/jamapediatrics.2013.311 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. 2009. https://jamanetwork.com/ [DOI] [PMC free article] [PubMed]
  • 9.Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380:499-505. Elsevier B.V. doi: 10.1016/S0140-6736(12)60815-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Azman AS, Al-Shangeeti T, Al-Shehade S, et al. Factors associated with CT-Scan repetition among pediatrics and its relationship with cancer risk: a systematic review and meta-analysis protocol. 2023. PREPRINT (Version 1) available at Research Square. doi: 10.21203/RS.3.RS-3148714/V1 [DOI]
  • 11.Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2000.
  • 12.Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Tamilwanan S, Aziz Z, Rong LY, Bitar AN, Zarzour RHA, Alshehade SA. Efficacy of GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists in managing MALFD: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2025;25:765. BioMed Central Ltd. doi: 10.1186/S12876-025-04358-0/FIGURES/9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Su YP, Niu HW, Chen JB, Fu YH, Xiao GB, Sun QF. Radiation dose in the thyroid and the thyroid cancer risk attributable to CT scans for pediatric patients in one general hospital of China. Int J Environ Res Publ Health. 2014;11:2793-2803. doi: 10.3390/ijerph110302793 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Meulepas JM, Ronckers CM, Smets AMJB, et al. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J Natl Cancer Inst. 2019;111:256-263. Oxford University Press. doi: 10.1093/JNCI/DJY104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shibata S, Shibamoto Y, Maehara M, Hobo A, Hotta N, Ozawa Y. Reasons for undergoing CT during childhood: can CT-Exposed and CT-Naive populations be compared? Dose Response. 2020;18:1559325820907011. SAGE Publications Inc. doi: 10.1177/1559325820907011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Osmond MH, Klassen TP, Wells GA, et al. Validation and refinement of a clinical decision rule for the use of computed tomography in children with minor head injury in the emergency department. CMAJ. Canadian Medical Association. 2018;190:E816-E822. doi: 10.1503/cmaj.170406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Inoue Y, Itoh H, Waga A, Sasa R, Mitsui K. Radiation dose management in pediatric brain CT according to age and weight as continuous variables. Tomography. 2022;8:985-998. doi: 10.3390/tomography8020079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Alzimami K. Assessment of radiation doses to paediatric patients in computed tomography procedures. Pol J Radiol. 2014;79:344-348. Termedia Sp. z.o.o. doi: 10.12659/pjr.890806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nikkilä A, Raitanen J, Lohi O, Auvinen A. Radiation exposure from computerized tomography and risk of childhood leukemia: finnish register-based case-control study of childhood leukemia (FRECCLE). Haematologica. Ferrata Storti Foundation. 2018;103:1873-1880. doi: 10.3324/haematol.2018.187716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Andrade FP, Neto RM, Oliveira R, et al. Pediatric minor head trauma: do cranial CT scans change the therapeutic approach? Clinics. Universidade de Sao Paulo. 2016;71:606-610. doi: 10.6061/clinics/2016(10)09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bernier M-O, Rehel J-L, Brisse HJ, et al. Radiation exposure from CT in early childhood: a French large-scale multicentre study. Br J Radiol. 2012;85:53-60. doi: 10.1259/bjr/90758403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Al-Nabhani K, Kakaria A, Syed Oman R, Zahran Al-Nabhani K, Kumar Kakaria A, Syed R. Computed tomography in management of patients with non-localizing headache. Med J. 2014;29(1):28-31. doi: 10.5001/omj.2014.07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Abuhamed J, Nikkilä A, Lohi O, Auvinen A. Trends of computed tomography use among children in Finland. Eur J Radiol Open. 2020;7:100290. Elsevier Ltd. doi: 10.1016/j.ejro.2020.100290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.De Gonzalez AB, Salotti JA, McHugh K, et al. Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions. Br J Cancer. 2016;114:388-394. Nature Publishing Group. doi: 10.1038/bjc.2015.415 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kadowaki Y, Hamada N, Kai M, Furukawa K. Evaluation of the lifetime brain/central nervous system cancer risk associated with childhood head CT scanning in Japan. Int J Cancer. 2021;148:2429-2439. John Wiley and Sons Inc. doi: 10.1002/ijc.33436 [DOI] [PubMed] [Google Scholar]
  • 27.Bosch de Basea M, Moriña D, Figuerola J, et al. Subtle excess in lifetime cancer risk related to CT scanning in Spanish young people. Environ Int. 2018;120:1-10. doi: 10.1016/j.envint.2018.07.020 [DOI] [PubMed] [Google Scholar]
  • 28.Livingston MH, Igric A, Vogt K, Parry N, Merritt NH. Radiation from CT scans in paediatric trauma patients: indications, effective dose, and impact on surgical decisions. Injury. 2014;45:164-169. doi: 10.1016/j.injury.2013.06.009 [DOI] [PubMed] [Google Scholar]
  • 29.Journy N, Roué T, Cardis E, et al. Childhood CT scans and cancer risk: impact of predisposing factors for cancer on the risk estimates. J Radiol Prot. 2016;36:N1-N7. doi: 10.1088/0952-4746/36/1/N1 [DOI] [PubMed] [Google Scholar]
  • 30.Gibson DA, Moorin RE, Semmens J, Holman DJ. The disproportionate risk burden of CT scanning on females and younger adults in Australia: a retrospective cohort study. Aust NZJ Publ Health. 2014;38:441-448. Wiley-Blackwell. doi: 10.1111/1753-6405.12278 [DOI] [PubMed] [Google Scholar]
  • 31.Nabaweesi R, Ramakrishnaiah RH, Aitken ME, et al. Authors’ reply. J Am Coll Radiol. 2018;15:825-826. Elsevier B.V. doi: 10.1016/j.jacr.2018.04.005 [DOI] [PubMed] [Google Scholar]
  • 32.Masjedi HR, Zamani H, Perota G, Omidi R, Razavi E, Zare MH. Estimating the risks of exposure-induced death associated with common computed tomography procedures. International Journal of Radiation Research. 2022;20:169-175. doi: 10.52547/ijrr.20.1.26 [DOI] [Google Scholar]
  • 33.Ceritli S, Dibek K, Çavuş UY, et al. Repeated cranial computed tomography findings in children with head trauma ПОВТОРНЫЕ РЕЗУЛЬТАТЫ ЧЕРЕПНОЙ КОМПЬЮТЕРНОЙ ТОМОГРАФИИ У ДЕТЕЙ С ТРАВМОЙ ГОЛОВЫ. Science & Healthcare. 2021;23:42. doi: 10.34689/SH.2021.23.1.005 [DOI] [Google Scholar]
  • 34.Niemann T, Colas L, Roser HW, et al. Estimated risk of radiation-induced cancer from paediatric chest CT: two-year cohort study. Pediatr Radiol. 2015;45:329-336. Springer Verlag. doi: 10.1007/s00247-014-3178-7 [DOI] [PubMed] [Google Scholar]
  • 35.Ata MM, Moradi A, Gharekhanloo F, Nikzad S. Risk estimation of thyroid cancer for children undergoing brain CT examinations. Original Article Middle East Journal of Cancer. 2022;113:143-149. doi: 10.30476/mejc.2021.85833.130 [DOI] [Google Scholar]
  • 36.Asgari A, Parach AA, Bouzarjomehri F, et al. Projected future risk of leukemia and brain tumors from unnecessary brain CT scans: a multi-center study in Iran. Radioprotection. 2021;56:25-32. EDP Sciences. doi: 10.1051/radiopro/2020073 [DOI] [Google Scholar]
  • 37.Asgari A, Parach AA, Bouzarjomehri F, et al. Projected future risk of leukemia and brain tumors from unnecessary brain CT scans: a multi-center study in Iran. 2021:25-32. doi: 10.1051/radiopro/2020073 [DOI] [Google Scholar]
  • 38.Cooper JN, Lodwick DL, Adler B, Lee C, Minneci PC, Deans KJ. Patient characteristics associated with differences in radiation exposure from pediatric abdomen-pelvis CT scans: a quantile regression analysis. Comput Biol Med. 2017;85:7-12. Elsevier Ltd. doi: 10.1016/j.compbiomed.2017.04.003 [DOI] [PubMed] [Google Scholar]
  • 39.Huang R, Liu X, He L, Zhou PK. Radiation exposure associated with computed tomography in childhood and the subsequent risk of cancer: a meta-analysis of cohort studies. Dose Response. 2020;18:1559325820923828. doi: 10.1177/1559325820923828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bosch de Basea Gomez M, Thierry-Chef I, Harbron R, et al. Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat Med. 2023;29:3111-3119. Nature Publishing Group. doi: 10.1038/s41591-023-02620-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Khawaja RDA, Singh S, Otrakji A, et al. Dose reduction in pediatric abdominal CT: use of iterative reconstruction techniques across different CT platforms. Pediatr Radiol. 2015;45:1046-1055. doi: 10.1007/S00247-014-3235-2 [DOI] [PubMed] [Google Scholar]
  • 42.Brady SL, Trout AT, Somasundaram E, Anton CG, Li Y, Dillman JR. Improving image quality and reducing radiation dose for pediatric CT by using deep learning reconstruction. Radiology. 2021;298:180-188. Radiological Society of North America Inc. doi: 10.1148/RADIOL.2020202317/SUPPL_FILE/RY202317SUPPF1F.JPG [DOI] [PubMed] [Google Scholar]
  • 43.Nagayama Y, Goto M, Sakabe D, et al. Radiation dose reduction for 80-kVp pediatric CT using deep learning-based reconstruction: a clinical and phantom study. AJR Am J Roentgenol. 2022;219:315-324. doi: 10.2214/AJR.21.27255 [DOI] [PubMed] [Google Scholar]
  • 44.Mese I, Altintas Mese C, Demirsoy U, Anik Y. Innovative advances in pediatric radiology: computed tomography reconstruction techniques, photon-counting detector computed tomography, and beyondri. Pediatr Radiol. 2024;54:1-11. doi: 10.1007/S00247-023-05823-2 [DOI] [PubMed] [Google Scholar]
  • 45.Nagayama Y, Oda S, Nakaura T, et al. Radiation dose reduction at pediatric CT: use of low tube voltage and iterative reconstruction. Radiographics. 2018;38:1421-1440. [Nagayama, Yasunori; Oda, Seitaro; Nakaura, Takeshi; Utsunomiya, Daisuke; Kidoh, Masafumi; Yamashita, Yasuyuki] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan. [Funama, Yoshinori] Kumamoto Univ, Fac Li. doi: 10.1148/rg.2018180041 [DOI] [PubMed] [Google Scholar]
  • 46.Cloyd CP, Macedone D, Merandi J, et al. A quality initiative to improve appropriate medication dosing in pediatric patients with obesity. Pediatr Qual Saf. 2024;9:e741. doi: 10.1097/PQ9.0000000000000741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gallo-Bernal S, Bedoya MA, Gee MS, Jaimes C. Pediatric magnetic resonance imaging: faster is better. Pediatr Radiol. 2023;53:1270-1284. doi: 10.1007/S00247-022-05529-X [DOI] [PubMed] [Google Scholar]
  • 48.Edwards AD, Arthurs OJ. Paediatric MRI under sedation: is it necessary? What is the evidence for the alternatives? Pediatr Radiol. 2011;41:1353-1364. doi: 10.1007/S00247-011-2147-7 [DOI] [PubMed] [Google Scholar]
  • 49.Ng J, Murphy A, Haouimi A. Paediatric immobilisation. Radiopaedia.org. 2020. doi: 10.53347/RID-75653 [DOI] [Google Scholar]
  • 50.Zygmont ME, Ikuta I, Nguyen XV, Frigini LAR, Segovis C, Naeger DM. Clinical decision support: impact on appropriate imaging utilization. Acad Radiol. 2023;30:1433-1440. Elsevier Inc. doi: 10.1016/j.acra.2022.10.006 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material - Factors Associated With CT Scan Repetition in Pediatrics and Its Relationship With Cancer Risk: A Systematic Review and Meta-Analysis

Supplemental Material for Factors Associated With CT Scan Repetition in Pediatrics and Its Relationship With Cancer Risk: A Systematic Review and Meta-Analysis by Tahani Al-Shangeeti, Rozilawati Ahmad, Salah A. Alshehade, Maisa Elzaki, Fahad A. Alatheem, Wala Al-Sharif, Khalid Suliman, Amjad Al-Shangeeti, Bandar Al-Shamrani, Abdullah Hanbali, Tariq Almuzaini, Mohammed Alnasser, Taher Althubyani, Abdullah Aljohani, Ahmed Mahdi Baba, Amal Zaki Alruwaili, Hamid Osman Hamid Osman and Mohammed Abdullah Alshawsh in Dose-Response.

Data Availability Statement

All data analyzed in this systematic review and meta-analysis are from published studies cited in the references. The datasets used for the meta-analysis are available from the corresponding author upon reasonable request.*


Articles from Dose-Response are provided here courtesy of SAGE Publications

RESOURCES